Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Academic rigor, journalistic flair
Articles on Immunotherapy
Displaying 1 - 20 of 42 articles
Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
New research has found that a parasite first identified in dogs could help stimulate the human immune system to attack cells of cancerous tumours.
October is awash in seas of pink T-shirts, balloons and ribbons in honor of Breast Cancer Awareness Month. But this messaging fails to recognize people who are not cured of the disease.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
Patients with blood cancer undergoing stem cell transplantation have a high risk of complications. The bacteria in their gut, however, can help their immune system recover and fight infections.
Pioneered by the Human Cell Atlas consortium, our understanding of the human body is about to be transformed – and with it, the way we treat and prevent disease
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.
Applying the principles of ecology and evolution could help oncologists anticipate cancer drug resistance and optimize their treatment plans for patients.
The parasite which causes toxoplasmosis has shown promise in treating difficult tumours in mice.
A diagnosis of metastatic breast cancer means having cancer for the rest of one’s life – a situation with very different needs and concerns compared to earlier stages of the disease.
People with HIV need to take daily medication to keep the virus at bay. A study has found that a new treatment combination could boost immunity and control virus levels even after stopping medication.
Whether or not you respond to a certain medicine or therapy doesn’t just depend on you. The microbes in your gut play a role in the success or failure of various drugs, including cancer therapies.
Researchers are trying to boost the power of our immune system by genetically altering our white blood cells and transforming them into super-soldiers to fight cancer.
Alex Trebek announced this week that his pancreatic cancer is in remission. A pancreatic cancer specialist explains the difficulties of the disease as well as new treatment advances.
Most cancer research has been done in Europe, there’s minimal data on African populations.
Genomics research is crucial to identify Africa-specific solutions to a range of diseases.
The cornerstone of our adaptive immune system is the ability to remember the various infections we have encountered. Quite literally, if it doesn’t kill you, it makes your immune system stronger.
In a remarkably short period of time, drugs that harness the power of the immune system, have been used to successfully treat many cancers.
Top contributors
-
Postdoctoral research scientist, Columbia University
-
Oncologist and Senior Lecturer, University of Newcastle
-
Professor of Neurosurgery, University of Florida
-
Professor of Sociology, Ball State University
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Graduate Student in Cancer Systems Biology, Rice University
-
Senior Research Fellow, University of Technology Sydney
-
CRUK Senior Lecturer Head and Neck Surgery, University of Southampton
-
Professor of Experimental Medicine, University of Southampton
-
Assistant Professor, Georgia State University
-
Professor of Interdisciplinary Parasitology, University of Nottingham
-
Director of Drug Discovery at MRC Technology and Honorary Professor, Queen Mary University of London
